We are live on
!
Find out more
TA
TLS Advisors Portfolio holdings
AUM
$42.1M
1-Year Est. Return
25.99%
This Fund
S&P 500
This Quarter
Est. Return
+2.24%
1 Year Est. Return
+25.99%
3 Year Est. Return
+65.03%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$24.7M
AUM Growth
+$1.41M
(+6%)
Cap. Flow
+$1.07M
Cap. Flow
% of AUM
4.33%
Top 10 Holdings %
Top 10 Hldgs %
96.56%
Holding
16
New
1
Increased
3
Reduced
2
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vale
VALE
|
+$653K |
| 2 |
Rio Tinto
RIO
|
+$319K |
| 3 |
BHP
BHP
|
+$292K |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$196K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Range Resources
RRC
|
+$341K |
| 2 |
Xenon Pharmaceuticals
XENE
|
+$29.9K |
| 3 |
Greenland Technologies Holding
GTEC
|
+$19K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 38.01% |
| 2 | Energy | 30.95% |
| 3 | Materials | 15.57% |
| 4 | Communication Services | 12.86% |
| 5 | Consumer Discretionary | 1.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
EQT Corp
EQT
$33.8B
| $6.1M | 24.66% |
150,800
| – | – |
|
2
Ovid Therapeutics
OVID
$444M
| $5.07M | 20.5% |
1,319,679
| – | – |
|
3
Meta Platforms (Facebook)
META
$1.59T
| $3.18M | 12.86% |
10,589
| – | – |
|
|
4
Vale
VALE
$63.2B
| $1.77M | 7.16% |
132,000
+48,000
| +57% | +$653K |
|
|
XOMA
5
DELISTED
Xoma
XOMA
| $1.7M | 6.88% |
120,665
| – | – |
|
|
6
Range Resources
RRC
$9.06B
| $1.55M | 6.28% |
47,923
-10,900
| -19% | -$341K |
|
7
OmniAb
OABI
$306M
| $1.3M | 5.25% |
250,185
| – | – |
|
|
8
Xenon Pharmaceuticals
XENE
$6.4B
| $1.13M | 4.56% |
32,956
-800
| -2% | -$29.9K |
|
|
9
BHP
BHP
$215B
| $1.05M | 4.24% |
18,440
+5,000
| +37% | +$292K |
|
|
10
Rio Tinto
RIO
$150B
| $1.03M | 4.17% |
16,200
+5,000
| +45% | +$319K |
|
11
Hovnanian Enterprises
HOV
$771M
| $393K | 1.59% |
3,872
| – | – |
|
12
iShares MSCI Singapore ETF
EWS
$1.03B
| $250K | 1.01% |
13,600
| – | – |
|
|
13
Regeneron Pharmaceuticals
REGN
$68.3B
| $205K | 0.83% |
+250
| New | +$196K |
|
|
NBIS
14
Nebius Group N.V.
NBIS
$55.4B
| $1K | ﹤0.01% |
17,811
| – | – |
|
|
NIRWW
15
DELISTED
Near Intelligence, Inc. Warrant
NIRWW
| $1K | ﹤0.01% |
10,000
| – | – |
|
|
16
Greenland Technologies Holding
GTEC
$14.5M
| – | – |
-12,054
| Closed | -$19K |
|
Similar funds
ACM
VEPM
SIM
FDG
GC
LSA
VAM
VI
TLS Advisors's Q3 2023 Portfolio in Review
As of Q3 2023, TLS Advisors held 16 positions worth $24.7M, up 6% from $23.3M the previous quarter. Its ten largest holdings account for 97% of the portfolio.
TLS Advisors deployed $1.07M of net new capital in Q3 2023, opening 1 new position and adding to 3 existing holdings. Its largest new stake was Regeneron Pharmaceuticals: 250 shares worth $205K.
By sector, the portfolio is most concentrated in Healthcare at 38% of assets, down from 39% a quarter earlier, followed by Energy and Materials.
On the sell side, the largest reduction was Range Resources, an estimated $341K trimmed.
- TLS Advisors's largest Q3 2023 buy was Regeneron Pharmaceuticals: 250 shares worth $205K.
- TLS Advisors added most to Vale in Q3 2023, an estimated $653K increase.
- TLS Advisors's biggest Q3 2023 reduction was Range Resources, cutting an estimated $341K.
- TLS Advisors fully exited Greenland Technologies Holding in Q3 2023, selling an estimated $19K.
- TLS Advisors's ten largest holdings make up 97% of its $24.7M portfolio in Q3 2023.
- TLS Advisors opened 1 new position and closed 1 in Q3 2023.
- TLS Advisors's portfolio value rose 6% quarter-over-quarter to $24.7M.
Based on TLS Advisors's 13F filing for Q3 2023, filed 16 Nov 2023.